Kezar Life Sciences, Inc.KZRNASDAQ
Loading
Year-over-year operating cash flow growth rate
5Y CAGR
+22.7%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
1 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q3 2025 | 23.17% |
| Q2 2025 | 25.57% |
| Q1 2025 | -2.17% |
| Q4 2024 | 3.82% |
| Q3 2024 | -2.72% |
| Q2 2024 | 25.51% |
| Q1 2024 | -20.45% |
| Q4 2023 | 6.06% |
| Q3 2023 | 6.46% |
| Q2 2023 | -3.55% |
| Q1 2023 | -31.34% |
| Q4 2022 | 2.92% |
| Q3 2022 | -23.11% |
| Q2 2022 | 0.19% |
| Q1 2022 | -20.15% |
| Q4 2021 | -11.32% |
| Q3 2021 | 23.69% |
| Q2 2021 | -56.10% |
| Q1 2021 | 10.21% |
| Q4 2020 | -0.62% |
| Q3 2020 | 8.33% |
| Q2 2020 | -21.56% |
| Q1 2020 | -15.13% |
| Q4 2019 | 12.66% |
| Q3 2019 | -7.04% |
| Q2 2019 | -15.10% |
| Q1 2019 | -22.42% |
| Q4 2018 | -18.87% |
| Q3 2018 | 33.75% |
| Q2 2018 | -84.52% |
| Q1 2018 | -133.04% |
| Q4 2017 | 25.80% |
| Q3 2017 | 5.43% |
| Q2 2017 | -14.46% |
| Q1 2017 | 0.00% |